• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞穿透肽的测试:对肿瘤靶向纳米抗体的结合、摄取和生物分布的影响

CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody.

作者信息

Collado Camps Estel, van Lith Sanne A M, Frielink Cathelijne, Lankhof Jordi, Dijkgraaf Ingrid, Gotthardt Martin, Brock Roland

机构信息

Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboudumc, 6525 GA Nijmegen, The Netherlands.

Department of Medical Imaging, Nuclear Medicine, Radboudumc, 6525 GA Nijmegen, The Netherlands.

出版信息

Pharmaceuticals (Basel). 2021 Jun 23;14(7):602. doi: 10.3390/ph14070602.

DOI:10.3390/ph14070602
PMID:34201507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8308549/
Abstract

Nanobodies are well-established targeting ligands for molecular imaging and therapy. Their short circulation time enables early imaging and reduces systemic radiation exposure. However, shorter circulation time leads to lower tracer accumulation in the target tissue. Cell-penetrating peptides (CPPs) improve cellular uptake of various cargoes, including nanobodies. CPPs could enhance tissue retention without compromising rapid clearance. However, systematic investigations on how the functionalities of nanobody and CPP combine with each other at the level of 2D and 3D cell cultures and in vivo are lacking. Here, we demonstrate that conjugates of the epidermal growth factor receptor (EGFR)-binding nanobody 7D12 with different CPPs (nonaarginine, penetratin, Tat and hLF) differ with respect to cell binding and induction of endocytosis. For nonaarginine and penetratin we compared the competition of EGF binding and performance of L- and D-peptide stereoisomers, and tested the D-peptide conjugates in tumor cell spheroids and in vivo. The D-peptide conjugates showed better penetration into spheroids than the unconjugated 7D12. Both in vivo and in vitro, the behavior of the agent reflects the combination of both functionalities. Although CPPs cause promising increases in in vitro uptake and 3D penetration, the dominant effect of the CPP in the control of biodistribution warrants further investigation.

摘要

纳米抗体是用于分子成像和治疗的成熟靶向配体。它们较短的循环时间有利于早期成像并减少全身辐射暴露。然而,较短的循环时间会导致示踪剂在靶组织中的积累减少。细胞穿透肽(CPPs)可改善包括纳米抗体在内的各种货物的细胞摄取。CPPs可以增强组织滞留,同时不影响快速清除。然而,目前缺乏关于纳米抗体和CPPs的功能如何在二维和三维细胞培养水平以及体内相互结合的系统研究。在这里,我们证明了表皮生长因子受体(EGFR)结合纳米抗体7D12与不同CPPs(九聚精氨酸、穿膜肽、Tat和人乳铁蛋白)的缀合物在细胞结合和内吞作用诱导方面存在差异。对于九聚精氨酸和穿膜肽,我们比较了表皮生长因子(EGF)结合的竞争性以及L-和D-肽立体异构体的性能,并在肿瘤细胞球体和体内测试了D-肽缀合物。D-肽缀合物比未缀合的7D12表现出更好的穿透球体的能力。在体内和体外,该制剂的行为反映了两种功能的结合。尽管CPPs在体外摄取和三维穿透方面有令人期待的增加,但CPPs在生物分布控制中的主导作用值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/44b47ceb1f31/pharmaceuticals-14-00602-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/90a698999e7f/pharmaceuticals-14-00602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/3146de073074/pharmaceuticals-14-00602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/25463fa32420/pharmaceuticals-14-00602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/b95be0c15011/pharmaceuticals-14-00602-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/228d0dd89d5c/pharmaceuticals-14-00602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/6eefc148aa6f/pharmaceuticals-14-00602-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/01303283c010/pharmaceuticals-14-00602-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/44b47ceb1f31/pharmaceuticals-14-00602-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/90a698999e7f/pharmaceuticals-14-00602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/3146de073074/pharmaceuticals-14-00602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/25463fa32420/pharmaceuticals-14-00602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/b95be0c15011/pharmaceuticals-14-00602-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/228d0dd89d5c/pharmaceuticals-14-00602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/6eefc148aa6f/pharmaceuticals-14-00602-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/01303283c010/pharmaceuticals-14-00602-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1546/8308549/44b47ceb1f31/pharmaceuticals-14-00602-g008.jpg

相似文献

1
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody.细胞穿透肽的测试:对肿瘤靶向纳米抗体的结合、摄取和生物分布的影响
Pharmaceuticals (Basel). 2021 Jun 23;14(7):602. doi: 10.3390/ph14070602.
2
Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides.三维肿瘤球体和外植体中的渗透:为细胞穿透肽的结构-活性关系增添新维度。
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1342-1349. doi: 10.1016/j.bbamem.2018.03.007. Epub 2018 Mar 14.
3
The pharmacokinetics of cell-penetrating peptides.细胞穿透肽的药代动力学。
Mol Pharm. 2010 Dec 6;7(6):2224-31. doi: 10.1021/mp100223d. Epub 2010 Oct 7.
4
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.使用针孔单光子发射计算机断层扫描/微型计算机断层扫描比较两种99mTc标记的抗表皮生长因子受体纳米抗体在小鼠体内的生物分布和肿瘤靶向性。
J Nucl Med. 2008 May;49(5):788-95. doi: 10.2967/jnumed.107.048538. Epub 2008 Apr 15.
5
Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.单剂量靶向HER2的白蛋白结合域融合纳米抗体-药物偶联物实现肿瘤的均匀靶向,可使小鼠肿瘤长期缓解。
Theranostics. 2021 Mar 13;11(11):5525-5538. doi: 10.7150/thno.57510. eCollection 2021.
6
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.通过一种新型双功能去铁胺螯合物,轻松标记抗表皮生长因子受体纳米抗体用于免疫 PET。
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):753-63. doi: 10.1007/s00259-010-1700-1. Epub 2011 Jan 6.
7
Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.细胞穿透肽修饰的靶向载药相变脂质纳米粒联合低强度聚焦超声用于肝癌精准治疗。
Theranostics. 2018 Feb 14;8(7):1892-1910. doi: 10.7150/thno.22386. eCollection 2018.
8
Cell penetration: scope and limitations by the application of cell-penetrating peptides.细胞穿透:细胞穿透肽应用的范围与局限
J Pept Sci. 2014 Oct;20(10):760-84. doi: 10.1002/psc.2672. Epub 2014 Aug 11.
9
Induction of splice correction by cell-penetrating peptide nucleic acids.细胞穿透肽核酸诱导剪接校正
J Gene Med. 2006 Oct;8(10):1262-73. doi: 10.1002/jgm.950.
10
Polymer Cancerostatics Containing Cell-Penetrating Peptides: Internalization Efficacy Depends on Peptide Type and Spacer Length.含细胞穿透肽的聚合物抗癌剂:内化效率取决于肽的类型和间隔长度。
Pharmaceutics. 2020 Jan 10;12(1):59. doi: 10.3390/pharmaceutics12010059.

引用本文的文献

1
The intracellular visualization of exogenous DNA in fluorescence microscopy.在荧光显微镜下观察细胞内的外源 DNA。
Drug Deliv Transl Res. 2024 Aug;14(8):2242-2261. doi: 10.1007/s13346-024-01563-4. Epub 2024 Mar 25.
2
Filtration and tubular handling of EWE-hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney disease.野生型小鼠和蛋白尿性肾病小鼠模型中补体抑制剂纳米抗体EWE-hC3Nb1的滤过及肾小管处理情况
FEBS Open Bio. 2024 Feb;14(2):322-330. doi: 10.1002/2211-5463.13752. Epub 2024 Jan 4.
3
Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.

本文引用的文献

1
Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.肿瘤穿透肽功能化 tenascin-C 抗体用于胶质母细胞瘤靶向治疗。
Curr Cancer Drug Targets. 2021;21(1):70-79. doi: 10.2174/1568009620666201001112749.
2
Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy.细胞穿透肽修饰的纳米粒子:缀合机制、理化性质及其在癌症诊断和治疗中的应用。
Int J Mol Sci. 2020 Apr 6;21(7):2536. doi: 10.3390/ijms21072536.
3
Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery.
抑 pyroptosis 纳米抗体阻断 GSDMD 孔形成。
Nat Commun. 2023 Dec 1;14(1):7923. doi: 10.1038/s41467-023-43707-z.
4
Nanobodies: Robust miniprotein binders in biomedicine.纳米抗体:生物医药领域中强大的微型蛋白结合剂。
Adv Drug Deliv Rev. 2023 Apr;195:114726. doi: 10.1016/j.addr.2023.114726. Epub 2023 Feb 7.
5
Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery.通过酶连接抗体和精氨酸 9 肽实现高效和细胞特异性的 siRNA 递送。
Sci Rep. 2021 Nov 8;11(1):21882. doi: 10.1038/s41598-021-01331-1.
转谷氨酰胺酶介导的纳米抗体聚乙二醇化用于靶向纳米药物递送。
J Mater Chem B. 2018 Feb 21;6(7):1011-1017. doi: 10.1039/c7tb03132g. Epub 2018 Feb 6.
4
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery.通过化学工程将多聚体细胞穿透肽与抗体结合,提高抗体的细胞内递送效率,从而改善抗体治疗方法。
J Control Release. 2020 Jun 10;322:200-208. doi: 10.1016/j.jconrel.2020.03.005. Epub 2020 Mar 14.
5
Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.穿膜肽立体化学对胰岛素载固体脂质纳米粒口服生物利用度的影响。
Int J Nanomedicine. 2019 Nov 25;14:9127-9138. doi: 10.2147/IJN.S225086. eCollection 2019.
6
Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours.纳米抗体的大小和亲和力动力学影响实体瘤的靶向和穿透。
J Control Release. 2020 Jan 10;317:34-42. doi: 10.1016/j.jconrel.2019.11.014. Epub 2019 Nov 14.
7
The Therapeutic Potential of Nanobodies.纳米抗体的治疗潜力。
BioDrugs. 2020 Feb;34(1):11-26. doi: 10.1007/s40259-019-00392-z.
8
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.使用纳米抗体对免疫检查点 LAG-3 进行无创成像:从研发到临床前应用。
Biomolecules. 2019 Sep 29;9(10):548. doi: 10.3390/biom9100548.
9
Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery.用于核成像和图像引导手术的基于靶向纳米抗体的分子示踪剂。
Antibodies (Basel). 2019 Jan 11;8(1):12. doi: 10.3390/antib8010012.
10
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade.免疫 PET 鉴定髓系细胞为 PD-1 阻断下抗肿瘤反应结局的关键贡献者。
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16971-16980. doi: 10.1073/pnas.1905005116. Epub 2019 Aug 2.